Rajasthan Drug Control Flags Cefixime, Tapentadol Among 8 NSQ Medicines in July
Jaipur: Rajasthan's Drug Control Organisation has reported that the overwhelming majority of medicines tested during July 2026 met the prescribed quality standards, with 579 out of 587 drug samples (98.64%) found to be of standard quality. Only eight samples (1.36%) were classified as Not of Standard Quality (NSQ), reflecting the state's continued surveillance efforts to ensure the availability of safe and effective medicines.
The monthly quality assessment was carried out by the Drug Testing Laboratory as part of the state's routine drug surveillance programme, which monitors the quality of medicines available in the market. The initiative is aimed at protecting public health by ensuring that medicines supplied to consumers comply with prescribed quality standards.
Principal Secretary (Medical and Health) Gayatri Rathore said the Drug Control Organisation regularly collects medicine samples from across Rajasthan and subjects them to scientific testing. She noted that the continuous surveillance programme is intended to safeguard public health and ensure that only quality medicines reach consumers.
According to the report, the eight NSQ samples included Cefixime with Lactic Acid Bacillus tablets, Nifedipine Sustained Release tablets, Formaldehyde solution, Betamethasone Sodium Phosphate injection, Metronidazole tablets, Cefixime and Ofloxacin dispersible tablets, Tapentadol Hydrochloride tablets, and Levocetirizine Dihydrochloride tablets. These medicines were identified during routine laboratory testing conducted under the state's quality monitoring programme.
The findings underscore Rajasthan's ongoing efforts to strengthen regulatory oversight of medicines circulating in the market through periodic sample collection and laboratory analysis. The Drug Control Organisation continues to monitor pharmaceutical products to detect medicines that fail to meet statutory quality standards and to help maintain the safety and efficacy of drugs supplied to patients.
NDTV reported that the July quality assessment demonstrated that nearly all medicines tested complied with prescribed standards, while a small proportion of samples were identified as Not of Standard Quality (NSQ) through the state's routine surveillance programme.
